Overview
GHRS market data
Price History
GHRS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.79 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.35 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $11.83 – $31.44 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.9B · P/B 2.82.
Company News
Guggenheim Maintains Buy on GH Research, Raises Price Target to $40Benzinga · Aug 7, 2026, 5:07 PM
Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $40Benzinga · Aug 7, 2026, 12:25 PM
Needham Maintains Buy on GH Research, Raises Price Target to $39Benzinga · Aug 6, 2026, 6:19 PM
GH Research Q2 EPS $(0.23) Beats $(0.30) EstimateBenzinga · Aug 6, 2026, 11:20 AM
Wells Fargo Initiates Coverage On GH Research with Overweight Rating, Announces Price Target of $44Benzinga · Jul 27, 2026, 12:49 PM
Shares of psychedelic-related biotech companies are trading higher amid sympathy with AtaiBeckley after the company announced it will be acquired by Lilly in a deal worth up to $3.8 billion.Benzinga · Jul 16, 2026, 4:43 PM
Why Is GH Research Stock Trading Higher on Thursday?Benzinga · Jul 16, 2026, 4:36 PM
GH Research Announces Publication Of Full Results From Its Phase 2a Trial In Postpartum DepressionBenzinga · Jun 4, 2026, 11:20 AM
These Analysts Revise Their Forecasts On GH Research After Q1 ResultsBenzinga · May 15, 2026, 3:05 PM
Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $35Benzinga · May 15, 2026, 12:25 PM